Activation of OX1R by orexin-A can reverse bone mass loss

To investigate whether the activation of OX1R by orexin-A can reverse bone mass loss induced by chronic intermittent hypoxia.

Related Keywords

China ,Germany ,Japan ,Jiancheng ,Jiangsu ,United States ,Yuyan ,Zhejiang ,Nanjing , ,Laboratory Animals ,National Institute Of Health ,Alkaline Phosphatase Color Development Kit Beyotime ,Committee Of Nanjing Medical University Approval ,Thermo Fisher ,Graphpad Software ,University Experimental Animal Center ,Exposed Cell Culture ,Institutional Animal Care ,Use Committee ,Nanjing Medical University ,National Institute ,Cell Counting ,Real Time Quantitative ,Sequences Used ,Cytoplasmic Extraction Reagents ,Thermo Fisher Scientific ,Millipore Immobilon ,Phosphatase Staining ,Phosphatase Color Development Kit ,Alkaline Phosphatase Assay Kit ,Pad Prism ,